Aptevo Therapeutics Inc

NASDAQ:APVO  
1.64
-0.06 (-3.53%)
7:59:24 PM EDT: $1.61 -0.03 (-1.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aptevo Therapeutics Inc Stock, NASDAQ:APVO

2401 4th Avenue, Suite 1050, Seattle, Washington 98121
United States of America
Phone: +1.206.838.0500
Number of Employees: 42

Description

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.